HUTCHMED (China) Limited (AIM:HCM)
London · Delayed Price · Currency is GBP · Price in GBX 222.00
+3.50 (1.60%)
Aug 29, 2025, 4:35 PM GMT+1
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 1.91 billion as of August 29, 2025. Its market cap has decreased by -22.48% in one year.
Market Cap
1.91B
Enterprise Value
993.77M
Revenue
439.54M
Ranking
n/a
PE Ratio
5.74
Stock Price
222.00
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 128.29M to 1.91B, an increase of 1,387.02%. That is a compound annual growth rate of 15.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 1.91B | -5.02% |
| Dec 31, 2024 | 2.01B | -16.84% |
| Dec 29, 2023 | 2.42B | 8.25% |
| Dec 30, 2022 | 2.23B | -50.85% |
| Dec 31, 2021 | 4.54B | 36.26% |
| Dec 31, 2020 | 3.33B | 31.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.83B |
| GSK plc | 58.51B |
| Haleon | 32.51B |
| Smith & Nephew | 12.04B |
| ConvaTec Group | 4.83B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 1.74B |
| Genus | 1.71B |